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Purpose of the study
In literature an association between HIV-infection and the
increased occurrence of autoantibodies has been reported.
The relation between autoantibodies and rheumatologi-
cal disease manifestations, however, remains uncertain.
The objective of this study is to assess rheumatologic man-
ifestations and prevalence of autoantibodies in a cohort of
HIV-positive individuals and to correlate these findings
with HIV-specific disease parameters under receipt of
HAART.
Methods
Documentation of clinical symptoms of autoimmune dis-
ease in 64 HIV-positive patients treated in the University
Clinic of Bonn. Screening of autoantibodies includes
rheumatoid factor, ANA, ANCA, cardiolipine antibodies,
thyroid antibodies and microsomal antibodies.
Summary of results
Twenty-one of 64 patients reported muscular or joint-
related complaints. None of the patients, however,
revealed sufficient ACR criteria for the diagnosis of rheu-
matoid arthritis. No correlation was found between mus-
cular and/or joint pain and the detection of any kind of
autoantibodies. In addition there was no correlation
between CD4-count, CDC-stage or level of HIV-viremia
and positivity of autoantibodies. A correlation was found,
however, between CD4-count and IgG-level (p = 0.015;
OR = 0.997). No correlation was found between co-infec-
tion (hepatitis, STD) in general and presence of autoanti-
bodies (p = 0.852; OR = 1.267; confidence interval =
0.106–15.193). Also, no correlation was found between
occurrence of autoantibodies and the receipt of HAART (p
= 0.725; OR = 0.376; confidence interval = 0.002–
86.851).
Conclusion
The presence of joint or muscle pain was high with
32.81% expressing corresponding complaints. Also, the
prevalence of autoantibodies was higher than in the gen-
eral population with 18.97%. In this small group of
patients, however, no correlation was found between HIV
disease stage markers and the occurrence of rheumatolog-
ical disease manifestations or presence of autoantibodies.
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